Ins2Akita mice exhibit hyperphagia and anxiety behavior via the melanocortin system

International Journal of Molecular Medicine

Volumn 19, Issue 4, 2007, Pages 649-652

  Asakawa, Akihiro ^a   Toyoshima, Megumi ^a   Inoue, Kayoko ^a   Koizumi, Akio ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Agouti related protein; Anxiety behavior; Diabetes mellitus; Feeding behavior; Ghrelin; Proopiomelanocortin

Indexed keywords

AGOUTI RELATED PROTEIN; AGOUTI-RELATED PROTEIN; INSULIN; MELANOCORTIN; MESSENGER RNA; PROOPIOMELANOCORTIN; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL; ANXIETY; ARTICLE; BODY WEIGHT; DIABETES MELLITUS; DISEASE MODEL; FEEDING BEHAVIOR; GENETICS; HYPERPHAGIA; METABOLISM; MOUSE; MOUSE MUTANT; PSYCHOLOGICAL ASPECT;

ANIMALS; ANXIETY; BODY WEIGHT; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; FEEDING BEHAVIOR; HYPERPHAGIA; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANOCORTINS; MICE; MICE, MUTANT STRAINS; PRO-OPIOMELANOCORTIN; RNA, MESSENGER;

EID: 34247859082     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.19.4.649     Document Type: Article

References (39)

1. Croft P and Hannaford PC: Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study. BMJ 298: 165-168, 1989. (Pubitemid 19039682)
2. Coughlin SS, Calle EE, Teras LR, Petrelli J and Thun MJ: Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159: 1160-1167, 2004. (Pubitemid 38747263)
3. Stegmayr B and Asplund K: Diabetes as a risk factor for stroke. A population perspective. Diabetologia 38: 1061-1068, 1995.
4. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A and Breteler MM: Diabetes mellitus and the risk of dementia: The Rotterdam study. Neurology 53: 1937-1942, 1999.
5. Vestergaard P, Rejnmark L and Mosekilde L: Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 48: 1292-1299, 2005. (Pubitemid 41186093)
6. Grigsby AB, Andersona RJ, Freedlanda KE, Clouse RE and Lustmana PJ: Prevalence of anxiety in adults with diabetes: A systematic review. J Psychosom Res 53: 1053-1060, 2002. (Pubitemid 36040653)
7. Lloyd CE, Dyert PH and Barnett AH: Prevalence of symptoms of depression and anxiety in a diabetes clinic population. Diabet Med 17: 198-202, 2000.
8. McGrady A and Horner J: Role of mood in outcome of biofeedback assisted relaxation therapy in insulin dependent mellitus. Appl Psychophysiol Biofeedback 24: 79-88, 2001. (Pubitemid 29510478)
9. Rubin RR and Peyrot M: Psychological issues and treatments for people with diabetes. J Clin Psychol 57: 457-478, 2001.
10. Anderson RJ, Freedeland KE, Clouse RE and Lustman PJ: The prevalence of comorbid depression in adults with diabetes. Diabetes Care 24: 1069-1078, 2001.
11. Yoshioka M, Kayo T, Ikeda T and Koizumi A: A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46: 887-894, 1997. (Pubitemid 27188269)
12. Wang J, Takeuchi T, Tanaka S, et al: A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest 103: 27-37, 1999. (Pubitemid 29031160)
13. Maurice T, Roman FJ, Su TP and Privat A: Beneficial effects of sigma agonists on the age-related learning impairment in the senescence-accelerated mouse (SAM). Brain Res 733: 219-230, 1996. (Pubitemid 26308600)
14. Tejedor-Real P, Costela C and Gibert-Rahola J: Neonatal handling reduces emotional reactivity and susceptibility to learned helplessness. Involvement of catecholaminergic systems. Life Sci 62: 37-50, 1998.
15. Asakawa A, Inui A, Momose K, Ueno N, Fujino MA and Kasuga M: Endomorphins have orexigenic and anxiolytic activities in mice. Neuroreport 9: 2265-2267, 1998.
16. Rubin RR and Peyrot M: Psychosocial problems and interventions in diabetes: a review of the literature. Diabetes Care 15: 1640-1657, 1992.
17. Rydall AC, Rodin GM, Olmsted MP, Devenyi RG and Daneman D: Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med 336: 1849-1854, 1997.
18. Lustman PJ, Griffith LS, Clouse RE, et al: Effects of nortriptyline on depression and glucose regulation in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 59: 241-250, 1997.
19. Black SA, Markides KS and Ray LA: Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with Type 2 diabetes. Diabetes Care 26: 2822-2828, 2003.
20. Booth D: Characteristics of feeding during streptozotocin-induced diabetes in the rat. J Comp Physiol Psychol 1238-1240, 1972.
21. Thorre K, Chaouloff F, Sarre S, Meeusen R, Ebinger G and Michotte Y: Differential effects of restraint stress on hippocampal 5-HT metabolism and extracellular levels of 5-HT in streptozotocin-diabetic rats. Brain Res 772: 209-216, 1997.
22. Ramanathan M, Jaiswal AK and Bhattacharya SK: Differential effects of diazepam on anxiety in streptozotocin-induced diabetic and non-diabetic rats. Psychopharmacology 135: 361-367, 1998. (Pubitemid 28254842)
23. Ramanathan M, Jaiswal AK and Bhattacharya SK: Hyperglycaemia in pregnancy: effects on the offspring behaviour with special reference to anxiety paradigms. Indian J Exp Biol 38: 231-236, 2000. (Pubitemid 30142023)
24. Bleasel AF and Yong LC: Streptozotocin-induced diabetic nephropathy and renal tumors in the rat. Experientia 38: 129-130, 1982. (Pubitemid 12183123)
25. Hirose K, Osterby R, Nozawa M and Gundersen HJ: Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int 21: 889-895, 1982.
26. Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW and Coffman TM: Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 290: F214-F222, 2006.
27. Kadowaki T, Miyake Y, Hagura R, et al: Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26: 44-49, 1984. (Pubitemid 14182349)
28. Kadowaki T, Kadowaki H, Mori Y, et al: A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 330: 962-968, 1994.
29. Halaas JL, Gajiwala KS, Maffei M, et al: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546, 1995.
30. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H and Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660, 1999. (Pubitemid 129516334)
31. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C and Hsueh AJ: Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 5750: 996-999, 2005. (Pubitemid 41611907)
32. Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R and Stark KL: Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 11: 593-602, 1997.
33. Spiegelman BM and Flier JS: Obesity and the regulation of energy balance. Cell 104: 531-543, 2001.
34. Nijenhuis WA, Oosterom J and Adan RA: AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol 15: 1664-1671, 2001.
35. Schwartz MW, Woods SC, Seeley RJ, Barsh GS, Baskin DG and Leibel RL: Is the energy homeostasis system inherently biased toward weight gain? Diabetes 52: 232-238, 2003.
36. De Souza J, Butler AA and Cone RD: Disproportionate inhibition of feeding in A(y) mice by certain stressors: a cautionary note. Neuroendocrinology 72: 126-132, 2000.
37. Harris RBS, Zhou J, Shi M, Redmann S, Mynatt RL and Ryan DH: Overexpression of agouti protein and stress responsiveness in mice. Physiol Behav 73: 599-608, 2001.
38. Krude H, Biebermann H, Luck W, Horn R, Brabant G and Gruters A: Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19: 155-157, 1998.
39. Thomsen AF, Kvist TK, Andersen PK and Kessing LV: The risk of affective disorders in patients with adrenocortical insufficiency. Psychoneuroendocrinology 31: 614-622, 2006.